News about Global Pharma

Alembic Pharmaceuticals Bags USFDA Final Approval for Diltiazem Hydrochloride Capsules

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cardizem CD Extended-Release Capsules, 120 mg, 180 mg, 240 mg, 300 mg, and 360 mg, of Bausch Health US, LLC.

Global Pharma | 12/11/2024 | By Aishwarya |  542

Lakeside Enters Medical Logistics Sector with Acquisition of Hupan Pharmaceutical

The acquisition, valued at RMB 4.0 million (USD 0.6 million), is anticipated to deliver approximately USD 7 million of annual revenues to Lakeside.

Global Pharma | 12/11/2024 | By Aishwarya |  201

Alteogen Signs Exclusive License Deal with Daiichi Sankyo to Develop Subcutaneous ENHERTU

Under the terms of the agreement, Daiichi Sankyo will acquire world-wide rights to use ALT-B4, Alteogen's novel hyaluronidase utilizing Hybrozyme Technology, to develop and commercialize a subcutaneous version of ENHERTU (fam-trastuzumab deruxtecan-nxki).

Global Pharma | 11/11/2024 | By Aishwarya |  489

Union Minister for Chemicals and Fertilizers Unveils Scheme for Strengthening Medical Device Industry

The scheme is a comprehensive scheme which targets critical areas of the medical device industry, covering manufacturing of key components and accessories, skill development, support for clinical studies, development of common infrastructure and industry promotion.

Global Pharma | 11/11/2024 | By Aishwarya |  267

Samsung Biologics Secures ISO Certifications for its Business Excellence

The certifications were presented by the British Standards Institution (BSI) during a ceremony held at Samsung Biologics' headquarters.

Global Pharma | 11/11/2024 | By Aishwarya |  619

Parallel Fluidics Secures USD 7 Million Seed Round to Boost Microfluidic Development

The funding will help drive the growth of the company's on-demand design and manufacturing platform, expand its hardware and software solutions, and commercialize its new product, MV-2.

Global Pharma | 08/11/2024 | By Aishwarya |  373

NJ Bio Partners with Charles River to Accelerate ADC Development

The biggest benefit of the Charles River and NJ Bio alliance is that clients can receive seamless complementary services to enhance outcomes and accelerate time-to-market for their ADCs.

Global Pharma | 08/11/2024 | By Aishwarya |  295

Microbiologics Acquires SensID to Expand its Portfolio in Diagnostic Quality Controls

The combined expertise of Microbiologics and SensID will empower both companies to deliver a broader portfolio of quality control solutions to further support diagnostic technology developers and healthcare professionals and ultimately improve patient care worldwide.

Global Pharma | 07/11/2024 | By Aishwarya |  502

Biosynth Strengthens Leadership Team with New Appointments

Matt Gunnison will succeed Urs Spitz, under whose guidance Biosynth has achieved remarkable growth and strengthened its position in the life sciences sector.

Global Pharma | 06/11/2024 | By Aishwarya |  380

Ionis Receives FDA Approval of New Drug Application for Donidalorsen

Donidalorsen is designed to reduce the production of prekallikrein (PKK), interrupting the pathway that leads to HAE attacks.

Global Pharma | 06/11/2024 | By Aishwarya |  867